{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-003136","form_type":"8-K","ticker":"PBSV","cik":"0001304161","company_name":"Pharma-Bio Serv, Inc.","filed_at":"2023-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.324642+00:00","generated_at":"2026-06-17T23:29:32.553059+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pharma-Bio Serv Q1 2023 revenue $4.2M (-$0.8M YoY); net income $0.4M (+$0.1M YoY)","bullets":["Quarterly revenue $4.2M, down from $5.0M in prior-year quarter.","Net income $0.4M, compared to $0.3M in same period last year.","CEO cites resource optimization in profitable markets driving gross profit improvement.","Company plans to continue maximizing resources to increase profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-003136","json":"https://secwatch.observer/filing/0001654954-23-003136.json","markdown":"https://secwatch.observer/filing/0001654954-23-003136.md","text":"https://secwatch.observer/filing/0001654954-23-003136.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1304161/000165495423003136/0001654954-23-003136-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1304161/000165495423003136/pbsv_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T23:29:32.553059+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"219dcca3afc62c7674522ab35f238b003914ddcf","claim":"Pharma-Bio Serv, Inc. reported quarter ended January 31, 2023 results: revenue approximately $4.2 million, net income approximately $0.4 million.","evidence_excerpt":"revenues for the quarter ended January 31, 2023 were approximately $4.2 million, a net decrease of approximately $0.8 million when compared to the same period last year. Net income for the quarter ended January 31, 2023 was approximately $0.4 million, an increase of approximately $0.1 million when compared to the same period last year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1304161/000165495423003136/0001654954-23-003136-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended January 31, 2023"},{"label":"Revenue","value":"approximately $4.2 million"},{"label":"Net income","value":"approximately $0.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}